Atrazine Lawsuit 2026 | Non-Hodgkin's Lymphoma Claims

Attorneys are investigating atrazine exposure claims involving people diagnosed with non-Hodgkin lymphoma (NHL).

These investigations focus on whether manufacturers adequately warned users about potential cancer risks associated with the herbicide, including risks to farmers and pesticide applicators.

A significant scientific development came in November 2025, when the International Agency for Research on Cancer (IARC) classified atrazine as “probably carcinogenic to humans.”

Its assessment combined limited human evidence with sufficient evidence of cancer in laboratory animals and strong mechanistic evidence in experimental systems.

Importantly, the human finding concerned NHL carrying a specific genetic change called the t(14;18) chromosomal translocation, not all forms of lymphoma/

This genetic change involves chromosomes 14 and 18 and can help abnormal cells escape the body’s normal process of programmed cell death.

Two case-control studies reviewed by IARC found elevated odds of translocation-positive NHL among people exposed to atrazine or triazine herbicides, without comparable increases for translocation-negative NHL.

However, the limited number of studies and imprecise estimates meant chance could not be confidently excluded.

IARC also identified experimental evidence involving oxidative stress, inflammation, immune suppression, and altered cell growth or survival.

A separate 2024 Agricultural Health Study analysis followed 53,562 pesticide applicators. It found no overall association between atrazine use and NHL across the cohort, but reported a 2.43-fold NHL rate among atrazine users in the under-50 age group compared with nonusers.

That subgroup estimate had a wide confidence interval, and the researchers did not establish a statistically significant difference in the association across age groups.

The finding warrants further investigation but should not be presented as a risk increase applying to everyone exposed.

Together, these findings provide important context for atrazine cancer claims while leaving questions unresolved.

IARC’s classification identifies a cancer hazard; it does not establish the risk from a particular exposure level or prove that atrazine caused an individual’s lymphoma.

Recent developments have highlighted the ongoing debate over pesticide safety, as new research documented widespread atrazine contamination in U.S. waterways while pesticide manufacturers secured significant legal victories against environmental and public health groups.

A U.S. Geological Survey study examining more than a decade of water samples found pesticides were commonly detected in rivers and streams across agricultural regions, with atrazine ranking among the chemicals most frequently identified.

Researchers concluded that multiple pesticides often occur together in waterways, raising continued concerns about long-term environmental and human exposure in farming communities.

At the same time, pesticide manufacturers have recently prevailed in several high-profile legal and regulatory disputes.

Among the developments, the U.S. Supreme Court ruled that certain state-law failure-to-warn claims involving EPA-approved pesticide labels may be preempted by federal law, while other federal agencies have issued decisions favorable to pesticide manufacturers in ongoing environmental challenges.

Although these rulings do not directly address whether atrazine causes cancer, they reflect the increasingly important role federal regulatory decisions are expected to play in future pesticide litigation.

The developments come as atrazine remains the subject of lawsuits alleging that long-term exposure increased the risk of non-Hodgkin lymphoma.

Plaintiffs contend manufacturers failed to adequately warn users about potential cancer risks despite scientific studies suggesting an association between atrazine exposure and lymphoma, while manufacturers continue to dispute those allegations.

As new environmental research and regulatory decisions emerge, the litigation over atrazine’s potential health effects is expected to remain closely watched.

A key issue in Atrazine litigation is the body of scientific research examining whether exposure to the herbicide may increase the risk of developing non-Hodgkin’s lymphoma (NHL).

Plaintiffs in Atrazine lawsuits frequently cite epidemiological studies and toxicological evidence suggesting that long-term exposure may contribute to the development of certain cancers, particularly among agricultural workers and individuals exposed through contaminated water sources.

Research involving farmers, pesticide applicators, and other agricultural populations has identified elevated rates of NHL among some individuals exposed to Atrazine and related triazine herbicides.

For example, a pooled analysis of case-control studies conducted as part of the North American Pooled Project found associations between exposure to several pesticides, including Atrazine, and increased risks of certain NHL subtypes.

The researchers noted that pesticide exposure patterns varied across study populations but concluded that some herbicides warranted further investigation for their potential role in lymphoma development.

Researchers have also examined cancer risks in communities exposed to Atrazine-contaminated drinking water.

One study evaluating environmental exposures in Nebraska reported that the combination of nitrate contamination and Atrazine exposure was associated with increased risks of certain NHL subtypes.

The authors suggested that co-exposure to agricultural contaminants may contribute to lymphoma risk and warranted additional study.

Studies evaluating combined nitrate and Atrazine exposure have produced particularly noteworthy findings.

Research published in Environmental Health Perspectives found that individuals exposed to both nitrate and Atrazine in drinking water experienced higher risks of certain NHL subtypes than those exposed to either contaminant alone.

The study highlighted the possibility that multiple agricultural contaminants may interact to influence cancer risk.

In addition to epidemiological research, scientists have investigated biological mechanisms that may help explain a connection between Atrazine exposure and cancer risk.

Laboratory and toxicological studies have linked Atrazine to endocrine disruption, oxidative stress, immune system alterations, and cellular changes that could contribute to carcinogenesis.

Reviews of Atrazine toxicology have discussed how these mechanisms may affect hormone regulation and immune function, both of which are relevant to cancer development.

As Atrazine litigation continues, scientific evidence concerning the herbicide’s potential relationship to non-Hodgkin’s lymphoma is expected to remain a central focus.

Future cases will likely involve extensive expert testimony regarding epidemiological findings, toxicological data, and the strength of the evidence supporting causation.

Ongoing research into exposure pathways, cancer mechanisms, and population health outcomes may further shape the scientific and legal landscape surrounding Atrazine-related claims.

In November 2025, the International Agency for Research on Cancer classified atrazine as probably carcinogenic to humans (Group 2A).

IARC did not endorse a broad claim covering all non-Hodgkin’s lymphoma cases.

Instead, IARC said the human evidence was limited for non-Hodgkin’s lymphoma that is positive for the t(14;18) chromosomal translocation, while the evidence for all NHL combined remained mixed.

IARC also said the overall classification rested on that limited human evidence plus sufficient animal evidence and strong mechanistic evidence in experimental systems.

A 2004 Agricultural Health Study analysis of more than 53,000 pesticide applicators found no association between atrazine and overall cancer incidence, and the elevated rate ratios reported for non-Hodgkin’s lymphoma were imprecise and did not establish a statistically reliable trend in the full cohort.

Older IARC material likewise noted that farmers in several studies tended to show increased NHL risk, but the excess could not be attributed to atrazine when NHL was treated as one broad category.

More recent research has shifted attention to lymphoma subtype and molecular markers, which is why the t(14;18) issue now matters so much.

IARC’s 2025 review explains that positive associations were observed for atrazine or triazine exposure and t(14;18)-positive NHL, but not for NHL cases that were negative for that translocation.

Earlier subtype-focused research moved in the same direction.

A study of agricultural risk factors reported that t(14;18)-positive NHL was associated with atrazine exposure, while corresponding associations were null or negative for t(14;18)-negative NHL.

A comprehensive scientific review has documented growing evidence that pesticide exposure may cause neurotoxic effects in humans and wildlife, raising renewed scrutiny over chemical safety and regulatory oversight.

Research published in the journal Discover Toxicology and summarized by Beyond Pesticides, several pesticide classes interfere with neurological function in vertebrates.

The review examined toxicological studies involving organophosphates, carbamates, and organochlorines.

Researchers reported that pesticide exposure can impair neurotransmission, generate oxidative stress, trigger neuroinflammation, and cause neuronal cell death.

Scientific literature links those biological effects to cognitive deficits, motor impairment, and abnormal neural development.

Researchers reported that neurological symptoms associated with pesticide exposure may include tremors, muscle weakness, seizures, memory loss, hallucinations, coordination problems, and respiratory difficulty.

The review also examined the effects of chronic low-dose pesticide exposure.

Toxicologists state that regulatory frameworks frequently focus on acute high-dose exposure during safety testing.

Researchers concluded that long-term exposure at lower concentrations may produce neurological damage that current regulatory models fail to fully evaluate.

The review also examined ecological impacts linked to pesticide contamination.

Scientific studies cited in the report describe neurological impairment and population declines among amphibians, reptiles, and other vertebrate species exposed to agricultural chemicals.

Organophosphate and carbamate pesticides interfere with acetylcholinesterase, an enzyme required for normal neurotransmission. Inhibition of the enzyme can lead to prolonged neuronal excitation and neurotoxicity in exposed organisms.

Evidence cited in the review also addresses potential human health implications.

Epidemiological research has linked pesticide exposure to neurological and developmental disorders, including attention-deficit hyperactivity disorder and autism spectrum disorder.

The review also discusses toxicological findings involving Paraquat and Glyphosate.

Laboratory research involving paraquat exposure has demonstrated neuroinflammation, systemic oxidative stress, and damage to dopaminergic neurons, which play a role in the development of Parkinson’s disease.

Researchers also highlighted the “cocktail effect,” a toxicological concept describing how combined exposure to multiple pesticides may produce additive or synergistic neurological harm.

Toxicologists report that simultaneous exposure to chemical mixtures may increase neurotoxicity beyond the impact of individual substances studied in isolation.

A recent executive action made by the current presidential administration has drawn attention for its potential impact beyond glyphosate, and into how other widely used herbicides like atrazine may be treated going forward.

On February 18, 2026, President Trump signed an executive order invoking the Defense Production Act to secure and expand domestic production of glyphosate-based herbicides and the key chemical inputs needed to make them, including elemental phosphorus.

The White House described these herbicides as critical to national defense and U.S. agricultural productivity, directing federal support to ensure their continued manufacture and supply domestically under a national security rationale.

That action, framed around boosting agricultural chemical supplies, shows a broader regulatory tone that industry observers and advocacy groups have described as more permissive toward pesticide availability and use.

Critics argue efforts to shield glyphosate production, including “immunity” for companies under aspects of the Defense Production Act, prioritize chemical availability over public health concerns.

While glyphosate and atrazine are regulated separately under federal law, the glyphosate order illustrates how current policy may favor maintaining access to widely used herbicides even amid health and environmental controversy.

Atrazine, like glyphosate, has a long history as a heavily used herbicide in the United States and recent research has highlighted controversial health and ecological impacts.

Independent agencies such as the International Agency for Research on Cancer have classified glyphosate and other herbicides as potentially hazardous, prompting legal investigations and public concern.

An Iowa Senate subcommittee has advanced legislation that would restrict cancer and injury lawsuits against pesticide manufacturers when product labels comply with federal EPA requirements, potentially reshaping how atrazine and other pesticide claims are litigated in state courts.

The bill would bar failure-to-warn claims by deeming EPA-approved labeling legally sufficient, even when plaintiffs allege manufacturers knew or should have known about health risks not reflected on the label.

While supporters argue the measure protects farmers and stabilizes agricultural access to pesticides, opponents contend it would prevent injured individuals from presenting evidence that federal labeling standards did not fully account for long-term or emerging health risks, including endocrine disruption.

Although the legislation is not atrazine-specific, the chemical was repeatedly cited during legislative debate as an example of a pesticide with contested health effects, including reproductive and developmental concerns.

If enacted, the bill could narrow one of the core liability theories used in atrazine lawsuits by shifting disputes away from jury determinations and toward regulatory compliance defenses.

The proposal remains under consideration, but its progress signals increasing legislative involvement in pesticide liability standards, which could influence how atrazine claims are pursued, defended, or preempted at the state level going forward.

Several conservation organizations and farming groups have filed a federal court action seeking to require the Environmental Protection Agency to complete and enforce safeguards addressing atrazine contamination in U.S. waterways.

The filing argues that the agency has delayed implementing court-mandated protections intended to limit environmental and health risks associated with the herbicide.

Atrazine remains one of the most widely used herbicides in the United States and is frequently detected in surface and drinking water, particularly in agricultural regions.

The lawsuit focuses on whether the EPA’s current and proposed regulatory framework adequately protects aquatic ecosystems and downstream water supplies.

The groups contend that existing thresholds would permit continued contamination across thousands of watersheds, while the agency maintains that its proposal reflects updated scientific review and risk assessment.

The challenge follows an EPA proposal, now under public comment, that would set a concentration equivalent level of concern for atrazine in surface waters at 9.7 parts per billion.

Supporters of the proposal say it balances environmental protection with agricultural needs; critics argue it is less protective than earlier benchmarks and does not sufficiently reduce runoff in heavily affected regions.

For atrazine litigation, the case highlights an ongoing regulatory question that often intersects with private lawsuits: whether federal standards are protective enough and how delays or changes in EPA action affect claims involving water contamination, human exposure, and environmental harm.

The court’s response to this request could influence both future regulatory enforcement and how atrazine-related risks are evaluated in parallel civil cases.

A recent report notes that the United States continues to allow widespread use of pesticides that have been restricted or banned in Europe, including atrazine.

According to the article, as of 2023 the European Union permits 444 pesticides while banning or declining approval for nearly 1,000 others.

By contrast, U.S. agriculture still uses hundreds of millions of pounds of chemicals that have been prohibited overseas.

Atrazine remains one of the most widely used herbicides in the U.S., even though it has been banned in the EU for years.

The report highlights concerns that pesticide drift, runoff, and groundwater contamination can expose not only farmworkers but also rural families and nearby communities.

Documented health concerns linked to long-term pesticide exposure include cancers such as leukemia and lymphoma, reproductive harm, birth defects, neurological disorders, and immune system effects

These issues are central to ongoing atrazine litigation.

Plaintiffs in atrazine lawsuits often allege that prolonged exposure, whether through agricultural application, contaminated water, or occupational contact, contributed to serious illnesses, including non-Hodgkin lymphoma and other cancers.

Comparisons to European regulatory standards are increasingly referenced in these cases, particularly where claimants argue that safer alternatives or stricter controls were feasible but not implemented in the U.S.

As scientific research and international regulatory decisions continue to evolve, courts reviewing atrazine claims are closely examining exposure pathways, risk assessments, and what manufacturers and regulators knew about potential long-term health effects.

The contrast between U.S. and EU policies may play a growing role in how juries evaluate whether adequate warnings and safeguards were in place.

The World Health Organization’s International Agency for Research on Cancer (IARC) has classified atrazine as Group 2A — “probably carcinogenic to humans.”

The determination was made by a working group of 22 scientists from 12 countries and published in The Lancet Oncology on November 21.

The panel found limited evidence in humans, including a positive association between atrazine exposure and non-Hodgkin lymphoma.

It also found sufficient evidence of cancer in laboratory animals and described strong mechanistic evidence showing that atrazine can trigger biological processes linked to cancer development.

Atrazine is one of the most widely used herbicides in the United States.

It is commonly applied to corn, sorghum, and sugarcane crops, as well as turf and lawn areas.

A prior EPA survey ranked it as the second most heavily used pesticide in the country.

The IARC classification does not automatically change U.S. regulations.

The agency evaluates carcinogenic risk but does not set policy. Regulatory decisions remain with national governments.

The U.S. Environmental Protection Agency has previously concluded that atrazine is “not likely to cause cancer in humans,” a position it has maintained in past assessments.

However, recent EPA ecological reviews and updates to atrazine’s aquatic toxicity thresholds indicate increased scrutiny over environmental and health impacts.

The new IARC classification is likely to intensify debate over atrazine’s safety profile and may influence ongoing regulatory reviews and related litigation involving cancer claims.

A comprehensive 2025 report highlights growing scientific and regulatory concerns surrounding atrazine, one of the most widely used herbicides in the United States.

According to the report, more than 70 million pounds of atrazine are applied annually, primarily on corn, sorghum, and sugarcane crops.

The report outlines substantial evidence that atrazine functions as an endocrine disruptor, interfering with hormone regulation in both humans and wildlife.

Studies cited link atrazine exposure to menstrual irregularities, reduced fertility, abnormal birth outcomes, and developmental effects.

Research in animal models demonstrates altered testosterone levels, impaired sperm production, and disruptions in reproductive organ development.

In November 2025, the World Health Organization’s International Agency for Research on Cancer (IARC) classified atrazine as “probably carcinogenic to humans,” citing limited evidence of non-Hodgkin lymphoma in humans and sufficient evidence of cancer in experimental animals.

The report further notes strong mechanistic evidence showing that atrazine can induce oxidative stress, DNA damage, immune suppression, inflammation, and hormonal disruption – biological pathways commonly associated with carcinogenesis

Water contamination remains a central issue.

Atrazine is among the most frequently detected contaminants in U.S. groundwater and public drinking water systems.

Federal monitoring has found widespread presence in streams and aquifers, and studies indicate the chemical can persist in groundwater for decades after application.

The U.S. maximum contaminant level (MCL) for atrazine in drinking water remains 3 µg/L, while the European Union banned atrazine in 2004 due to groundwater contamination concerns.

The report also revisits prior litigation.

In 2012, Syngenta agreed to a $105 million settlement with U.S. water utilities over atrazine contamination claims.

Advocacy groups have also challenged EPA reapprovals of the herbicide, arguing that regulatory safeguards fail to adequately address contamination risks and public health impacts.

As regulatory reviews continue and scientific scrutiny expands, atrazine remains under significant public health, environmental, and legal examination.

New peer-reviewed research published in Sustainability is adding to the scientific discussion surrounding atrazine’s long-term environmental persistence and potential human health implications.

The study examines how widely used herbicides – including atrazine – remain active in soil and water systems, move through agricultural runoff, and accumulate in surrounding ecosystems.

The researchers describe atrazine as a highly mobile compound, meaning it does not easily stay confined to the field where it is applied. Instead, it can migrate into groundwater, streams, and lakes, particularly in high-use agricultural regions.

Because atrazine breaks down slowly in certain environmental conditions, repeated seasonal application may contribute to ongoing background contamination in surface and drinking water sources.

The study also discusses how chronic, low-dose exposure to pesticide mixtures—rather than isolated single-chemical exposure—can create biological stress at the cellular level.

In lay terms, this means that even when each chemical is present at levels regulators consider “acceptable,” combined exposures may still affect hormone systems, immune response, and cellular repair mechanisms.

Atrazine has long been studied as an endocrine disruptor, meaning it can interfere with the body’s hormone signaling.

Hormones regulate growth, reproduction, metabolism, and immune function, so disruption may have broad downstream effects.

A recent investigative feature, Of Corn and Cancer: Iowa’s Deadly Water Crisis, details how agricultural runoff, particularly nitrates and pesticides, has overwhelmed parts of Iowa’s drinking water system and intensified concerns about long-term chemical exposure in farming communities.

While the article focuses heavily on nitrate pollution from fertilizer and livestock manure, it also underscores the widespread, ongoing use of herbicides like atrazine across millions of corn acres.

The report explains that Iowa applies massive quantities of nitrogen fertilizer and manure each year, and that runoff into rivers has increased significantly over the past two decades.

During heavy rains in 2025, nitrate levels in the Des Moines and Raccoon Rivers rose so high that water utilities struggled to maintain compliance with federal drinking water standards.

The article also notes that multiple pesticides – including atrazine and 2,4-D – are routinely detected in Iowa waterways, and that federal regulation typically evaluates chemicals one at a time rather than as combined “mixtures”.

This broader contamination picture matters in the atrazine litigation.

Plaintiffs in atrazine lawsuits allege that long-term exposure, particularly in agricultural regions where the chemical is heavily applied, contributed to cancers such as non-Hodgkin’s lymphoma (NHL) and other hormone-related diseases.

The Iowa reporting reinforces a key theme in those cases: exposure is not isolated or short-term. Instead, it can be chronic, cumulative, and intertwined with other agricultural chemicals in drinking water.

The article highlights research linking atrazine exposure to non-Hodgkin’s lymphoma and prostate and kidney cancers among pesticide applicators.

While causation in any individual case must be evaluated through medical and scientific evidence, the growing body of epidemiological research strengthens arguments that sustained exposure in high-use states may elevate cancer risk.

New reporting and educational materials on atrazine exposure continue to highlight concerns about groundwater contamination, drinking water safety, and long-term health risks associated with one of the most widely used herbicides in the United States.

A recent overview of atrazine exposure explains that nearly 75% of stream water samples and 40% of groundwater samples tested in agricultural regions contained traces of atrazine.

The same materials note that atrazine has been detected in a large percentage of public water systems and private wells, particularly in Midwestern states where corn and sorghum production is concentrated.

Atrazine is designed to kill weeds, but it is chemically persistent. It does not break down quickly in soil or water.

After rainfall, it can move through runoff into lakes and rivers or leach into underground aquifers.

Because roughly half of U.S. drinking water comes from groundwater sources, contamination of aquifers raises long-term public health questions.

The U.S. Environmental Protection Agency (EPA) currently sets a maximum contaminant level (MCL) of 3 parts per billion (ppb) in drinking water.

Federal regulators have stated that atrazine is “not likely to be carcinogenic” at regulated exposure levels.

However, various studies cited in the exposure materials describe findings that have raised concerns, including:

• Endocrine disruption effects in amphibians at very low concentrations
• Associations in some epidemiological research with non-Hodgkin’s lymphoma (NHL)
• Reports of reproductive and hormonal impacts in both animal and human studies

To explain this clearly:

An endocrine disruptor is a chemical that interferes with hormones.

Hormones control growth, reproduction, and immune function.

Even small disruptions during critical development periods may have lasting effects.

In the early 2000s, research groups reported elevated rates of non-Hodgkin’s lymphoma among certain populations with herbicide exposure, although regulatory agencies have maintained that existing data does not establish a definitive causal link.

A new investigative report examining Iowa’s rising cancer rates is adding renewed attention to the role of agricultural pesticides, including atrazine, in long-running public health and product liability debates.

The article, “How pesticides help fuel Iowa’s cancer crisis,” details how Iowa applies more than 53 million pounds of pesticides annually, with herbicides used on 96–97% of corn acres.

Iowa devotes nearly three-fourths of its land to agriculture, and the report notes that pesticide application has intensified as farm operations have grown larger over time.

Atrazine, historically one of the most widely used herbicides in the Midwest, remains part of that chemical landscape.

Emerging Science and Changing Conclusions

One of the most significant developments discussed in the report involves updated findings from the long-running Agricultural Health Study (AHS), which has tracked nearly 89,000 farmers and their spouses since 1993.

While earlier analyses in 2011 did not show strong cancer associations for atrazine, researchers later revisited the same population with additional years of data.

According to the article, revised findings published in 2024 found that atrazine use was associated with lung and multiple other forms of cancer.

Researchers quoted in the piece emphasize that scientific conclusions can evolve as more long-term exposure data becomes available.

This evolving body of research is central to ongoing atrazine litigation nationwide. Plaintiffs in atrazine cancer lawsuits argue that long-term exposure, particularly in agricultural communities, contributed to diagnoses including non-Hodgkin lymphoma and other cancers.

Defense arguments, by contrast, frequently rely on earlier regulatory findings or older epidemiological assessments.

The “Regulatory Gap” Argument

The report also highlights what environmental health researchers describe as a “gray area” between emerging science and regulatory policy.

Atrazine remains approved for use in the United States, even though other countries have imposed restrictions or bans.

For litigation purposes, this regulatory lag is significant. In toxic exposure cases, plaintiffs must typically show that:

• The chemical is capable of causing the type of cancer alleged (general causation), and
• The plaintiff’s exposure was sufficient to contribute to their disease (specific causation).

When new scientific findings emerge after a product has already been widely used for decades, courts are often asked to evaluate whether manufacturers should have anticipated those risks earlier, warned more aggressively, or taken additional safety measures.

A recent water filtration advisory out of New Hampshire’s Lakes Region underscores a growing reality in the atrazine debate: contamination is not limited to large farming states.

Even in regions with moderate agricultural activity, private well owners may be exposed to detectable levels of atrazine in groundwater.

Atrazine is one of the most widely used herbicides in the United States.

Because it is persistent in soil and highly mobile in water, it can leach into groundwater after rainfall or irrigation runoff. Unlike municipal water systems, private wells are not routinely regulated or monitored by federal authorities.

That means homeowners may be unaware of low-level, long-term exposure unless they conduct independent testing.

Testing in parts of New England has detected atrazine in private wells, sometimes approaching or exceeding the EPA’s Maximum Contaminant Level (MCL) of 3 parts per billion.

While that limit is considered federally permissible, critics argue it does not fully account for chronic exposure, mixture effects, or endocrine disruption — particularly in vulnerable populations.

The advisory highlights that standard pitcher filters and boiling water do not remove atrazine. Reverse osmosis systems, however, are capable of removing up to 98–99% of dissolved herbicides at the molecular level.

The growing consumer demand for advanced filtration reflects increasing public concern over agricultural chemical exposure through drinking water.

New reporting examining rising cancer rates in Iowa is adding fuel to ongoing concerns about the health impacts of long-term agricultural chemical exposure, including widely used herbicides like atrazine.

According to the American Cancer Society, roughly 2 million new cancer cases are projected in the U.S. in 2025, with more than 618,000 cancer deaths expected this year.

In heavily agricultural states such as Iowa, researchers and residents are questioning whether intensive chemical use may be contributing to disproportionately high cancer rates.

Iowa is one of the most farm-intensive states in the country. Nearly 31 million of its 35.7 million acres are devoted to agriculture.

The state leads the nation in corn production, a crop that relies heavily on herbicides such as atrazine. Atrazine remains one of the most widely applied herbicides in U.S. agriculture.

Recent scientific literature continues to identify associations between agricultural pesticide exposure and increased cancer risk.

A 2024 study published in Frontiers in Cancer Control and Society found that higher agricultural pesticide use was significantly associated with increased rates of multiple cancers, including non-Hodgkin lymphoma (NHL), leukemia, bladder cancer, lung cancer, colon cancer, pancreatic cancer, and others, particularly in regions with heavy agricultural productivity.

The Midwest showed some of the strongest correlations.

Separate research in GeoHealth reported statistically significant associations between pesticide mixtures and pediatric cancers in Nebraska, including leukemia and brain cancers.

Scientists have also increasingly focused on how herbicides may affect the immune system, hormone regulation, and DNA stability — biological pathways relevant to blood cancers such as NHL.

Although the recent Iowa reporting highlights several agricultural chemicals, atrazine remains a central point of concern in litigation and regulatory debates because of its widespread use and documented endocrine-disrupting properties.

Endocrine disruption means interference with the body’s hormone system, which plays a role in immune function and cancer development.

In the ongoing atrazine non-Hodgkin’s lymphoma lawsuits, plaintiffs allege that chronic exposure to the herbicide contributed to immune system dysfunction and ultimately lymphoma diagnoses.

Defendants maintain that atrazine remains registered by federal regulators and that current scientific evaluations do not establish causation.

As courts continue to evaluate expert testimony in these cases, the broader public health discussion around agricultural chemical exposure, particularly in high-use farm states, is likely to remain part of the conversation.

The growing body of epidemiological data linking pesticide-intensive regions with higher cancer incidence may influence how judges and juries assess risk, foreseeability, and regulatory adequacy in future atrazine litigation.

National debate is intensifying over whether U.S. policy should continue allowing pesticides linked to cancer,  including atrazine, when alternatives exist.

Recent reporting highlights how federal pesticide regulation shifted from the “zero tolerance” approach under the 1958 Delaney Clause, which banned carcinogens in processed food, to today’s risk-based model under the 1996 Food Quality Protection Act.

Instead of prohibiting cancer-causing substances outright, current policy allows pesticide residues in food if exposure is estimated to fall below certain thresholds.

Critics argue that this threshold model underestimates real-world exposure.

Modern research increasingly examines endocrine disruption, immune system effects, oxidative stress, and chemical mixtures – factors that are not always fully captured in traditional regulatory testing.

A 2024 study in Frontiers in Cancer Control and Society reported strong correlations between agricultural pesticide use and elevated rates of multiple cancers, including non-Hodgkin’s lymphoma (NHL).

The associations were particularly pronounced in heavily agricultural regions of the Midwest. While the study did not isolate atrazine specifically, atrazine remains one of the most widely used herbicides in those same regions.

Other recent epidemiological research has linked exposure to atrazine and similar herbicides with hormone disruption and increased cancer risk, including breast and prostate cancers.

Atrazine is widely recognized as an endocrine disruptor, meaning it interferes with normal hormone signaling, a biological pathway that experts frequently examine in cancer litigation.

In the context of the atrazine non-Hodgkin’s lymphoma lawsuits, this broader regulatory debate is significant. Plaintiffs argue that long-term exposure to atrazine contributed to immune system dysfunction and lymphoma development.

Defendants maintain that federal regulators continue to permit atrazine’s use based on existing safety evaluations.

The legal battle often centers on whether current regulatory standards adequately reflect modern scientific understanding, particularly regarding low-dose exposure, cumulative effects, and long-term health impacts.

As scientific literature continues to evolve, courts are expected to closely evaluate whether emerging research strengthens claims that chronic pesticide exposure, including atrazine, can increase the risk of blood cancers such as NHL.

New peer-reviewed research is continuing to examine how long-term pesticide exposure may contribute to the development of hematologic cancers, including non-Hodgkin’s lymphoma (NHL).

Recent findings highlight biological mechanisms that strengthen arguments already central to atrazine-related litigation.

The study evaluates how chronic exposure to certain agricultural chemicals may disrupt immune system function, promote oxidative stress, and interfere with normal lymphocyte regulation.

In simple terms, oxidative stress occurs when toxic exposure overwhelms the body’s ability to repair cellular damage.

Over time, that damage can affect white blood cells — the same cells involved in many forms of lymphoma.

Non-Hodgkin’s lymphoma is a cancer that begins in the lymphatic system, which is part of the immune system.

Several epidemiological studies over the past two decades have reported elevated NHL risks among agricultural workers and individuals with repeated pesticide exposure.

The newer research builds on that foundation by exploring how pesticide mixtures and long-term exposure patterns may increase cancer susceptibility.

In atrazine litigation, causation remains the central dispute.

Plaintiffs allege that chronic occupational or environmental exposure to atrazine contributed to the development of NHL. Manufacturers continue to dispute that link.

However, courts closely evaluate whether scientific literature demonstrates:

• Biological plausibility (does the chemical have a mechanism that could cause the disease?)
• Consistent epidemiological findings
• Dose-response patterns (does higher exposure correlate with higher risk?)

Research addressing immune dysfunction, endocrine disruption, and cellular damage is frequently cited in expert reports to support the biological plausibility element of these claims.

As atrazine cases move forward, updated toxicology and cancer-mechanism research may play a key role in expert admissibility hearings and summary judgment motions.

Courts are expected to closely examine whether the expanding body of scientific literature sufficiently supports claims that atrazine exposure can increase the risk of NHL in certain populations, particularly agricultural workers.

The scientific debate continues, but ongoing research is increasingly being incorporated into litigation strategy on both sides of the atrazine-related cancer cases.

A recent overview discussing glyphosate and atrazine highlights continued environmental and health concerns surrounding these widely used herbicides.

While both chemicals remain common in agriculture, atrazine in particular continues to draw scrutiny because of its persistence in water and potential biological effects.

According to the report, atrazine is frequently used for pre-emergence weed control in crops such as corn and sugarcane.

However, it has been linked to contamination of rivers, lakes, and potentially drinking water sources through agricultural runoff.

The article also discusses research suggesting that atrazine may interfere with hormone systems in wildlife, particularly amphibians, by disrupting normal endocrine function.

Endocrine disruption means a chemical can interfere with the body’s hormone signaling. Hormones regulate growth, development, metabolism, and reproduction.

When that signaling is altered, it may affect fertility, development, or other biological processes.

The report also references ongoing concerns about potential links between long-term exposure to these herbicides and certain cancers, including non-Hodgkin’s lymphoma and other hormone-related cancers, which remain central to current litigation

The report further notes broader concerns about biodiversity impacts and potential long-term health risks from chronic exposure.

Although regulatory agencies continue to evaluate acceptable exposure thresholds, ongoing atrazine lawsuits frequently center on claims that manufacturers failed to adequately warn about contamination risks and endocrine-related effects.

Atrazine remains one of the most widely used herbicides in the United States, with roughly 70 million pounds applied each year.

It is frequently detected in rivers, lakes, groundwater, and drinking water systems across large agricultural regions.

Federal data has identified contamination in more than 11,000 watersheds, and millions of Americans are estimated to receive drinking water with measurable atrazine levels.

Health concerns surrounding atrazine have intensified in recent years.

Researchers have linked long-term exposure to endocrine disruption, reproductive harm, and certain cancers.

Notably, scientists at the National Cancer Institute have reported associations between atrazine exposure and non-Hodgkin’s lymphoma (NHL), a cancer that affects the lymphatic system – the body’s infection-fighting network.

In simple terms, non-Hodgkin’s lymphoma develops when white blood cells called lymphocytes begin to grow uncontrollably. Many pesticide lawsuits focus on whether chronic exposure to agricultural chemicals increases the risk of these abnormal immune cell changes.

In atrazine litigation, plaintiffs allege that prolonged exposure, especially through contaminated water or occupational contact, contributed to their NHL diagnosis.

Claims often center on:

• The chemical’s widespread presence in drinking water
• Alleged failure to adequately warn about cancer risks
• Scientific studies suggesting immune system and hormonal disruption

Atrazine’s classification as an endocrine disruptor is important in these lawsuits.

Endocrine disruptors interfere with hormones, which regulate immune function, cell growth, and reproduction.

Plaintiffs argue that long-term hormonal interference may contribute to immune system dysfunction and cancer development.

The legal debate mirrors regulatory tension.

While atrazine has been banned in dozens of countries due to groundwater contamination concerns, it remains approved in the U.S., with allowable levels in drinking water that critics argue are too high.

That regulatory backdrop often becomes part of the courtroom argument over whether manufacturers knew or should have known about potential cancer risks.

As NHL pesticide lawsuits continue to move forward nationwide, atrazine is increasingly being examined alongside other agricultural chemicals.

The central question in these cases is not simply whether atrazine is widely used, but whether long-term exposure meaningfully increases the risk of developing non-Hodgkin’s lymphoma and whether adequate warnings were provided.

New reporting on pesticide contamination is drawing renewed attention to atrazine’s presence in drinking water supplies and how long-term exposure may impact human health.

According to a recent analysis of pesticide contamination in water systems, agricultural chemicals like atrazine can enter groundwater and surface water through rainfall runoff and irrigation, eventually reaching reservoirs and aquifers used for public drinking water.

The report highlights several concerns that mirror allegations raised in ongoing atrazine lawsuits:

• Environmental persistence: Atrazine is chemically stable and can remain in water sources for extended periods. Some breakdown byproducts may also retain biological activity.
• Endocrine disruption: Atrazine has been widely studied for its ability to interfere with hormone systems. In simple terms, it can mimic or block natural hormones in the body, potentially affecting reproductive development, fertility, and thyroid function.
• Long-term health risks: Research has linked certain pesticide exposures to cancers, including non-Hodgkin’s lymphoma, as well as neurological and immune system effects. Lawsuits involving atrazine often cite these types of long-term exposure risks.
• Treatment and monitoring limits: Standard water treatment methods do not always fully remove pesticide residues, and not all emerging contaminants are consistently tested for in municipal systems.

For atrazine litigation, drinking water contamination is a central issue. Many claims allege that individuals were exposed not through direct occupational use, but through everyday environmental exposure, particularly in agricultural regions where atrazine use is common.

As regulatory debates continue over acceptable atrazine levels in waterways, plaintiffs in pending lawsuits argue that long-term, low-dose exposure through contaminated drinking water may carry risks that were not adequately disclosed or mitigated.

The intersection of environmental contamination data and human health research remains a key battleground in ongoing atrazine cases.

A newly published study found that farmers exposed to pesticides had measurable residues of 28 different pesticide compounds in their blood and urine samples.

The research used advanced laboratory testing methods, including gas chromatography–mass spectrometry (GC-MS) and high-performance liquid chromatography (HPLC), to detect trace chemical levels.

According to the study, every tested sample showed multiple pesticide residues, including organophosphates, pyrethroids, neonicotinoids, and herbicides such as atrazine and glyphosate.

These chemicals are widely used in modern agriculture.

The study explains that organophosphates can affect the nervous system by interfering with enzymes that regulate brain signaling.

Pyrethroids and neonicotinoids are also linked to neurological and endocrine effects.

Herbicides such as glyphosate and atrazine have been associated in scientific literature with cancer risk and hormone disruption

Importantly, the researchers emphasize that farmers often face repeated exposure through spraying, handling treated crops, inhalation, and skin contact, especially when protective equipment is limited.

The study highlights concerns about long-term health effects, including neurological disorders, endocrine disruption, reproductive problems, and certain cancers.

In the context of ongoing pesticide litigation, findings like these are significant because they:

• Demonstrate that agricultural workers can have documented internal exposure, not just environmental contact.
• Support arguments that chronic exposure can lead to long-term health consequences.
• Reinforce the need for clearer warnings, stronger safety protocols, and regular medical monitoring.

While the study does not determine legal liability, it adds to the broader scientific discussion about occupational pesticide exposure and potential long-term health risks.

Atrazine is one of the most widely used herbicides in the United States and it is commonly applied to cornfields.

Because it breaks down slowly and dissolves in water, it can move into nearby streams, lakes, and groundwater.

That means people who rely on private wells or live near agricultural areas may face higher chances of exposure.

According to public health summaries, atrazine exposure has been associated with cardiovascular and reproductive effects.

Long-term exposure above federal limits has been linked to risks such as pre-term delivery, low birth weight, and certain developmental issues.

A 2024 update from the Agricultural Health Study also reported associations between atrazine exposure and certain cancers among pesticide applicators.

The U.S. Environmental Protection Agency (EPA) has set a Maximum Contaminant Level (MCL) for atrazine in public drinking water at 0.003 mg/L to reduce potential long-term health risks

Public water systems are required to test and report atrazine levels. However, private wells are not routinely monitored unless homeowners request testing.

Atrazine litigation that involves Non-Hodgkin’s Lymphoma centers on whether long-term exposure to contaminated water on agricultural drift can contribute to immune system dysfunction and blood cancers.

NHL affects the lymphatic system which is part of the body’s immune defense.

Scientific discussions about atrazine’s potential impact on immune function, endocrine disruption, and chronic low-dose exposure are directly relevant to claims that prolonged contact with the chemical may increase lymphoma risk.

In these cases, plaintiffs argue that manufacturers knew or should have known about potential cancer risks and failed to provide adequate warnings to communities with sustained exposure.

Practical steps families can take

• Avoid entering treated fields for at least 12 hours after application
• Prevent children from playing in soil or surface water shortly after pesticide application
• If you use a private well near agricultural land, ask your local health department about testing
• Consider granular activated carbon filtration, which has been shown to reduce atrazine levels in drinking water

A newly published study in GeoHealth is drawing attention in atrazine litigation after researchers found statistically significant links between long-term agricultural pesticide exposure and increased rates of pediatric cancers in Nebraska.

The study analyzed pesticide use data from 93 Nebraska counties between 1992 and 2014 and compared it with state cancer registry records for children under age 20.

Researchers examined exposure to 32 commonly used agrichemicals, including atrazine, and evaluated the impact of real-world chemical mixtures rather than single pesticides in isolation.

The findings were notable.

Researchers reported that every 10% increase in pesticide mixture exposure was associated with a 36% increase in brain and central nervous system (CNS) cancers in children.

They also found elevated associations with leukemia and overall pediatric cancer rates.

The study emphasized that children are particularly vulnerable due to developing organs, higher intake of air and food relative to body weight, and proximity to agricultural runoff and pesticide drift.

Atrazine was identified as one of the consistently applied herbicides across the counties studied.

Although atrazine is classified by some agencies as “not classifiable” regarding human carcinogenicity, the researchers stressed that regulatory classifications often evaluate chemicals individually.

The study instead focused on cumulative exposure, concluding that evaluating chemicals in isolation may underestimate the combined impact of multiple agrichemicals.

For atrazine litigation, this research is significant because it supports a broader exposure theory frequently raised in court: that agricultural communities are exposed to mixtures of pesticides, and health effects may result from combined exposures rather than a single product alone.

The study may also influence expert testimony regarding long-term, low-dose exposure and the potential vulnerability of children living in farming regions.

While the authors note limitations common to population-based studies, such as the inability to measure individual-level exposure, the findings add to an expanding body of scientific literature examining pesticide exposure and pediatric cancer risk.

A newly published epidemiological study is adding fresh scientific weight to concerns already central to atrazine litigation.

Researchers analyzing more than two decades of cancer data in Nebraska found that higher exposure to agricultural pesticide mixtures was associated with significant increases in childhood cancer rates, including brain, central nervous system, and blood cancers.

The study, published in GeoHealth in February 2025, examined pediatric cancer cases from 1992 to 2014 and compared them with county-level pesticide use data.

After adjusting for other factors, researchers reported that a 10% increase in combined pesticide exposure correlated with a 36% increase in childhood brain and CNS cancers, a 23% increase in leukemia, and a 30% increase in overall pediatric cancer rates.

Unlike prior research that focused on single chemicals, this study evaluated real-world exposure to multiple pesticides used together, a condition common in agricultural regions.

While atrazine was not isolated as the sole cause, the findings are notable because atrazine is one of the most widely used herbicides in U.S. agriculture and is frequently present in the same exposure mixtures studied.

Plaintiffs in atrazine cases have long argued that regulatory reviews underestimate health risks by evaluating chemicals in isolation, rather than accounting for cumulative exposure.

The authors also emphasized that children are uniquely vulnerable to pesticide exposure due to developing organs, hormone sensitivity, and higher relative intake of air, water, and food.

They acknowledged limitations, including the lack of individual biomonitoring data, but concluded that the results strengthen the evidence connecting agricultural pesticide exposure to pediatric cancers and warrant closer scrutiny by regulators and public health agencies.

In ongoing atrazine litigation, studies like this are likely to be cited to support claims that existing safety thresholds fail to account for real-world exposure conditions, especially for children living in farming communities.

The U.S. Environmental Protection Agency is reconsidering how much atrazine can be present in streams and lakes before mitigation is required, a move that could affect how atrazine-related health and environmental claims are evaluated in court.

Under a proposal finalized in late 2024, the EPA would allow atrazine concentrations up to 9.7 parts per billion (ppb) in surface waters before regulatory action is triggered.

This represents a shift from the 3.4 ppb level the agency identified as protective in earlier scientific assessments, while still remaining below some higher thresholds previously considered.

Atrazine is one of the most widely used herbicides in the United States, particularly in corn production, and it has been repeatedly detected in drinking water supplies.

Numerous studies have linked atrazine exposure to endocrine disruption, meaning it can interfere with hormone systems.

Research has associated atrazine with reproductive effects in wildlife, altered hormone signaling in mammals, and increased risks of birth complications and certain cancers.

The EPA has stated that its current proposal reflects a re-evaluation of scientific data reviewed by an advisory panel and that it does not anticipate human health risks at the proposed level.

Critics, however, argue that documented biological effects have been observed at concentrations well below 1 ppb, raising questions about whether the revised threshold adequately protects public health and aquatic ecosystems.

From a litigation standpoint, changes to EPA benchmarks are closely watched because regulatory standards often shape how courts evaluate foreseeability, warnings, and reasonableness.

Plaintiffs in atrazine cases frequently rely on historical EPA findings and scientific literature to argue that risks were known long before injuries occurred.

Defendants, in contrast, point to current regulatory positions to argue compliance with federal guidance.

The proposal is currently open for public comment.

Its final outcome may influence future atrazine lawsuits by reframing how regulators define “acceptable” exposure, even as scientific studies continue to examine long-term health effects associated with low-level, chronic atrazine exposure.

A federal court ruling striking down weakened federal oversight of genetically engineered (GE) crops is reverberating through atrazine litigation, where plaintiffs have long argued that lax regulation allowed pesticide-intensive farming systems to expand without adequate safety review.

In December 2024, a U.S. district court invalidated a 2020 rule that had largely exempted GE crops from federal oversight.

The court found that U.S. Department of Agriculture unlawfully abandoned its own scientific conclusions by allowing most GE crops to enter the market without meaningful review.

The judge ruled that the agency’s approach conflicted with prior expert findings and was unsupported by the scientific record.

This matters for atrazine claims because many GE crops are engineered specifically to tolerate heavy herbicide use.

Over time, those systems have driven higher and more persistent application of weed-killing chemicals, including atrazine.

The court recognized that these crop systems have contributed to escalating pesticide use, herbicide-resistant “superweeds,” environmental contamination, and downstream harm to farmers, communities, and ecosystems.

The decision reinforces a key theory raised in atrazine lawsuits: that regulatory rollbacks allowed chemical-dependent farming practices to expand despite known risks.

The court emphasized that federal agencies had previously acknowledged these dangers but reversed course without addressing them.

In simple terms, the ruling says regulators cannot ignore scientific warnings and let industry police itself when public health and environmental impacts are at stake.

By restoring federal oversight of GE crops, the decision strengthens arguments that increased atrazine exposure was foreseeable and preventable.

Plaintiffs may point to the ruling as evidence that weakened regulation, not lack of knowledge, enabled widespread pesticide reliance, reinforcing claims that atrazine-related harms stem from systemic regulatory failures rather than isolated use.